These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20649409)

  • 1. The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.
    Haug S; Lakew T; Habtemariam G; Alemayehu W; Cevallos V; Zhou Z; House J; Ray K; Porco T; Rutar T; Keenan J; Lietman TM; Gaynor BD
    Clin Infect Dis; 2010 Sep; 51(5):571-4. PubMed ID: 20649409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
    Skalet AH; Cevallos V; Ayele B; Gebre T; Zhou Z; Jorgensen JH; Zerihun M; Habte D; Assefa Y; Emerson PM; Gaynor BD; Porco TC; Lietman TM; Keenan JD
    PLoS Med; 2010 Dec; 7(12):e1000377. PubMed ID: 21179434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma.
    Keenan JD; Sahlu I; McGee L; Cevallos V; Vidal JE; Chochua S; Hawkins P; Gebre T; Tadesse Z; Emerson PM; Gaynor BD; Lietman TM; Klugman KP
    J Pediatric Infect Dis Soc; 2016 Jun; 5(2):222-6. PubMed ID: 27199475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae.
    Batt SL; Charalambous BM; Solomon AW; Knirsch C; Massae PA; Safari S; Sam NE; Everett D; Mabey DC; Gillespie SH
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2765-9. PubMed ID: 12936971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field.
    Maher MC; Alemayehu W; Lakew T; Gaynor BD; Haug S; Cevallos V; Keenan JD; Lietman TM; Porco TC
    PLoS One; 2012; 7(1):e29407. PubMed ID: 22272234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.
    O'Brien KS; Emerson P; Hooper PJ; Reingold AL; Dennis EG; Keenan JD; Lietman TM; Oldenburg CE
    Lancet Infect Dis; 2019 Jan; 19(1):e14-e25. PubMed ID: 30292480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments.
    Keenan JD; Klugman KP; McGee L; Vidal JE; Chochua S; Hawkins P; Cevallos V; Gebre T; Tadesse Z; Emerson PM; Jorgensen JH; Gaynor BD; Lietman TM
    J Infect Dis; 2015 Mar; 211(6):988-94. PubMed ID: 25293366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
    Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
    Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.
    Gaynor BD; Holbrook KA; Whitcher JP; Holm SO; Jha HC; Chaudhary JS; Bhatta RC; Lietman T
    Br J Ophthalmol; 2003 Feb; 87(2):147-8. PubMed ID: 12543738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
    Gladstone RA; Bojang E; Hart J; Harding-Esch EM; Mabey D; Sillah A; Bailey RL; Burr SE; Roca A; Bentley SD; Holland MJ
    Clin Microbiol Infect; 2021 Jun; 27(6):864-870. PubMed ID: 32750538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
    Hicks LA; Chien YW; Taylor TH; Haber M; Klugman KP;
    Clin Infect Dis; 2011 Oct; 53(7):631-9. PubMed ID: 21890767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-monthly azithromycin administration for trachoma.
    Malhotra-Kumar S; Coenen S; Klugman KP; Goossens H
    Lancet; 2009 Aug; 374(9688):449; author reply 449-50. PubMed ID: 19665641
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.
    Leach AJ; Shelby-James TM; Mayo M; Gratten M; Laming AC; Currie BJ; Mathews JD
    Clin Infect Dis; 1997 Mar; 24(3):356-62. PubMed ID: 9114185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical ocular antibiotics induce bacterial resistance at extraocular sites.
    Gaynor BD; Chidambaram JD; Cevallos V; Miao Y; Miller K; Jha HC; Bhatta RC; Chaudhary JS; Osaki Holm S; Whitcher JP; Holbrook KA; Fry AM; Lietman TM
    Br J Ophthalmol; 2005 Sep; 89(9):1097-9. PubMed ID: 16113356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.